Already have an account? log in
This article is FREE for you
Create a free account and join institutional investors, analysts and strategists from the world's largest banks
By submitting your email address you agree to receive communication by email
The Problem With The Russell 2000
It made an already precarious situation worse.
That's one way to describe the knock-on effect of la
OR, subscribe now for unlimited access
By submitting your email address you agree to receive communication by email
By submitting your email address you agree to receive communication by email
This may be affected by the surge of early stage biotech and uber-growth tech/consumer-tech names. Those kinds of stocks will have large negative EBIT and thus depress the R2K’s aggregate EBIT. However, the reality is that no-one expects them to have positive interest coverage, and they don’t depend on debt financing – those are purely equity-financed models.
Thanks jyl. I appreciate your comment. That nuance hadn’t occurred to me. Definitely worth considering.